Tag Archives: Cubist Pharmaceuticals

Kineta: Creative Financing Bridges the "Valley of Death"

At a time when burst bubbles have created uncertainty for investors in the biomedical realm, it’s smart for a drug company to make use of new legislation and emerging trends in venture capital. This is particularly true in spurring confidence in that translational area of drug development many deem the “Valley of Death”. PharmExec caught […]
Posted in Biotech, Deals, leadership, R&D, Regulatory, Strategy | Also tagged , , , , , , , , , , , , , , | Leave a comment
  • Categories

  • Meta